Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection
about
RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathwaySmall G proteins in the cardiovascular system: physiological and pathological aspectsRho kinase proteins--pleiotropic modulators of cell survival and apoptosisDifferential regulation of adhesion complex turnover by ROCK1 and ROCK2C3G overexpression promotes the survival of rat-derived H9C2 cardiomyocytes by p-ERK1/2.Elevated expression of C3G protein in the peri-infarct myocardium of rats.Focal adhesion kinase and endothelial cell apoptosis.Poldip2 controls vascular smooth muscle cell migration by regulating focal adhesion turnover and force polarization.PLCĪµ, PKD1, and SSH1L transduce RhoA signaling to protect mitochondria from oxidative stress in the heart.Cyclic mechanical stretch decreases cell migration by inhibiting phosphatidylinositol 3-kinase- and focal adhesion kinase-mediated JNK1 activation.Female adult mouse cardiomyocytes are protected against oxidative stress.Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection.RhoA-mediated signaling up-regulates hepatocyte growth factor gene and protein expression in response to apoptotic cellsILK mediates the effects of strain on intestinal epithelial wound closureThe SmgGDS splice variant SmgGDS-558 is a key promoter of tumor growth and RhoA signaling in breast cancer.Rho-kinase in development and heart failure: insights from genetic modelsRhoA signaling in cardiomyocytes protects against stress-induced heart failure but facilitates cardiac fibrosis.Rho kinase as a therapeutic target in cardiovascular disease.Survivin expression induced by endothelin-1 promotes myofibroblast resistance to apoptosis.Focal adhesion kinase and its role in skeletal muscle.Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancerElectrical and mechanical stimulation of cardiac cells and tissue constructs.RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomasElevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsisRhoA modulates functional and physical interaction between ROCK1 and Erk1/2 in selenite-induced apoptosis of leukaemia cells.Substance P is required for the pathogenesis of EMCV infection in miceProgesterone enhances vascular endothelial cell migration via activation of focal adhesion kinase.Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Revisited and revised: is RhoA always a villain in cardiac pathophysiology?Lysophospholipid receptor activation of RhoA and lipid signaling pathways.The sarcomeric M-region: a molecular command center for diverse cellular processes.Signaling Pathways in Cardiac Myocyte Apoptosis.Validity of SW982 synovial cell line for studying the drugs against rheumatoid arthritis in fluvastatin-induced apoptosis signaling modelPro-survival effect of Dock180 overexpression on rat-derived H9C2 cardiomyocytesRhoA-mediated signaling in mechanotransduction of osteoblasts.Delay of cell cycle progression and induction death of cancer cells on type I collagen fibrils [corrected].Knockdown of CkrL by shRNA deteriorates hypoxia/reoxygenation-induced H9C2 cardiomyocyte apoptosis and survival inhibition Via Bax and downregulation of P-Erk1/2.Targeted focal adhesion kinase activation in cardiomyocytes protects the heart from ischemia/reperfusion injuryPI3K Phosphorylation Is Linked to Improved Electrical Excitability in an In Vitro Engineered Heart Tissue Disease Model System.
P2860
Q24314983-DFAAA92F-C6B5-4CA2-8F05-3A75A4397503Q27010607-4BD8B4FB-14F3-4505-9EDB-F99FCC8FB34CQ27023537-45D81D92-3711-483A-945A-50DE0FAF327FQ27309003-5A496458-EAE2-4C96-ACE1-DCF44B3B13A2Q30009853-B2604650-31AC-4786-A99C-37BB24ED368FQ30009950-F5EF7840-84BF-4498-B595-E1FF0224F67DQ30459602-34BB84B3-6F32-4A6C-8F65-EC5E1C3B7248Q30589425-C5C1CCBA-D8DC-472B-9FED-DCB7FFE69CDFQ33670240-0EF00494-C2C3-4EA3-8B18-CBFF35AEEFAAQ33717490-8D3AE3D1-155B-4430-A6CC-E4593D300B6CQ33819441-73999E20-1EA6-4497-83D8-A28E5C52D9DCQ34150494-B0B34B2B-7F8C-4C57-B81C-33D8B9829A27Q34580332-E18448D1-2CB5-4B2C-9693-22213C0FEB88Q34597585-634FB6F6-2525-4B1D-A2B8-8CF1B1E1538DQ34845829-1FFF3EA0-E9CB-4E57-B6A2-3F153CAB3E46Q34893701-44412F45-3A73-419E-8953-45DFE35AB6CDQ34989031-1DB27628-F2AC-4D03-BDBD-025D286346ADQ35352722-F1C5E329-612E-478D-8D0A-752ABAF7DFA8Q35621434-B5B14863-8162-43EC-BEB3-E873C2BA8139Q36319611-50A00C8C-2DBE-46F1-BD4B-645A79745DB3Q36368354-357FBFB5-69F7-4AAC-B7CF-2432EDEE3F7CQ36414288-EB775A48-D316-4E45-AAC9-EA65D84199F7Q36421781-1F8004C7-0FBF-44AB-8A8E-20FD60070AF0Q36763119-76786311-961F-491F-959A-B7FFFA457256Q36986113-95497FFB-B19F-4EE7-8A3D-EABCDABC9883Q37062037-78319C98-170D-4B87-951B-F5243A3401E7Q37186717-68BA0FDB-B972-43E8-A3B6-B2E86360FFC3Q37295760-91C48676-ABEE-4566-BC7A-8B75C05668B4Q37450106-BC4FCE70-8698-4FAE-87DF-405287F6B9CAQ37766125-166599E2-A32B-403A-8679-C8C7BA4E5B57Q38044174-7D0D9908-F492-4EBC-9FC4-FC8BA415F622Q38471353-A284E6A9-CD45-401B-B44B-7251489498B4Q38768739-2EBBCC96-8C6D-4E86-B2E2-4D5B1331F306Q38877668-EE984A40-719B-461E-8E76-F664FBA25076Q39211484-7F91AC9C-A1EF-4E0E-B5A3-A3ACDF1AD5C1Q39379231-4DCEAE05-54A0-4FC9-ABA5-96DECE60E7CBQ39673554-E463F071-7019-4A68-9D25-4B1830B546A6Q41372912-D2B865B9-FA03-4515-A56B-8E6F057A6D24Q41841885-53E2F24B-EBB7-4788-B36A-2C2DB2B49321Q41944612-20348F27-1183-4215-8F14-6751C07E0389
P2860
Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection
description
2008 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Ō“Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2008 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ¤Õ„ÕÆÕæÕ„Õ“Õ¢Õ„ÖÕ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
article publiƩ dans la revue scientifique Journal of Biological Chemistry
@fr
artĆculu cientĆficu espublizĆ”u en 2008
@ast
im Dezember 2008 verƶffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedeckĆ½ ÄlĆ”nok (publikovanĆ½ 2008/12/19)
@sk
vÄdeckĆ½ ÄlĆ”nek publikovanĆ½ v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/12/19)
@nl
Š½Š°ŃŠŗŠ¾Š²Š° ŃŃŠ°ŃŃŃ, Š¾ŠæŃŠ±Š»ŃŠŗŠ¾Š²Š°Š½Š° Š² Š³ŃŃŠ“Š½Ń 2008
@uk
name
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@ast
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@en
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@nl
type
label
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@ast
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@en
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@nl
prefLabel
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@ast
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@en
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@nl
P2093
P2860
P3181
P356
P1476
Focal adhesion kinase as a Rho ...... n and cardiomyocyte protection
@en
P2093
Dominic P. Del Re
Joan Heller Brown
Shigeki Miyamoto
P2860
P304
35622ā35629
P3181
P356
10.1074/JBC.M804036200
P407
P577
2008-12-19T00:00:00Z